We cordially invite you to the 4th Symposium of the BU Interdisciplinary Neuroscience Research Centre: From Clinical Applications to Neuro-Inspired Computation on Friday, the 16th of January 2026, 9:30-15:00 at the Lees Lecture Theatre (Talbot Campus, Poole House -outside).
The symposium consists of a journey from clinical case studies to new, emerging experimental and computational methodologies underpinning future translational applications. It is an opportunity for informal discussions on grant proposals and to explore shared interests with our external guests from the NHS and collaborating EU universities. The provisional schedule is:
9:30. Coffee.
9:50. Welcome Address and Keynote talk: Dr Mihalis Doumas, Queen’s University Belfast.
10.45-11:00. Coffee Break and Networking.
11:00-11:50. Session I. Clinical Neuroscience.
11.50 -12.50. Lunch and Grants Discussion.
12.50-13:45. Keynote talk: Dr Andre Rupp, University of Heidelberg.
13:45-14:00 Coffee Break and Networking.
14:00-14:50. Session II. Neuro-Inspired Computation.
14:50-15:00. Concluding Remarks and Invitation to become a member of the INRC network.
If you have any queries, please do not hesitate to contact Ellen Seiss, eseiss@bournemouth.ac.uk or Emili Balaguer-Ballester, eb-ballester@bournemouth.ac.uk.
Thank you very much, and we are looking forward to seeing you there.
Kind regards,
Ellen and Emili, on behalf of all of us.











3C Event: Research Culture, Community & Can you Guess Who? Friday 20 March 1-2pm
Beyond Academia: Exploring Career Options for Early Career Researchers – Online Workshop
UKCGE Recognised Research Supervision Programme: Deadline Approaching
SPROUT: From Sustainable Research to Sustainable Research Lives
BRIAN upgrade and new look
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease